Navigation Links
FFF Enterprises Selects A10 Networks' AX Series Advanced Traffic Manager
Date:4/25/2008

AX Series Delivers MyFluVaccine Portal a Next-generation Server Load

Balancer Platform for Web Application Delivery

SAN JOSE, Calif., April 25 /PRNewswire/ -- A10 Networks(R) today announced that FFF Enterprises, the nation's largest distributor of plasma products, vaccines and other biopharmaceuticals, selected and deployed A10's AX Series Advanced Traffic Manager to provide a Web application delivery platform for its MyFluVaccine(TM) portal. MyFluVaccine,(TM) delivered by FFF Enterprises, is the nation's first online vaccine portal, allowing vaccine providers to order a dedicated supply of vaccines for guaranteed delivery on the dates they choose. FFF Enterprises selected A10's AX Series to load balance its Web servers, especially during peak usage conditions, to ensure the MyFluVaccine portal is always available and performing as desired for its customers.

To prepare for the peak flu vaccine ordering season, FFF enterprises began evaluating Juniper's DX line of server load balancers. However, shortly after the initial evaluation, Juniper announced it will end of life its DX family with a smooth transition for customers. FFF Enterprises concurrently read about A10's AX Series Advanced Traffic Manager family in the news, highlighting recent independent third-party performance tests from the Tolly Group, which proved that AX delivers over double the performance at less than half the price of incumbents. As a result, FFF Enterprises chose to evaluate the AX Series.

"We found the AX Series at the perfect time. After reading positive stories about its price/performance advantage over incumbents we tested the AX in our environment and discovered that the claims we read were true," said Bob Coates, VP of Technology for FFF Enterprises. "A10's AX Series provides us with a high-performance server load balancer solution to ensure MyFluVaccine(TM) is always performing and available."

The key AX Series features that FFF Ente
'/>"/>

SOURCE A10 Networks
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems
2. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
3. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
4. Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China
5. CJPS Enterprises Spins Off New Company for Intellectual Property Marketing
6. Nu Skin Enterprises Announces Increase in Quarterly Dividend
7. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
8. Nu Skin Enterprises to Present at Bank of America 2008 Consumer Conference
9. CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline
10. Nu Skin Enterprises to Announce First Quarter 2008 Results
11. CJPS Enterprises Announces a Series of Seminars on Automotive Diversification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... (PRWEB) October 01, 2014 Between 23 ... in the U.S., according to figures from the National ... Diseases Association (AARDA), and many of them have something ... of having undiagnosed celiac disease. Gluten Free Therapeutics, ... awareness of undiagnosed celiac disease by publishing a series ...
(Date:10/1/2014)... 01, 2014 Diet Doc understands that many ... lose weight and their dieting attempts could be easily sabotaged ... hormone diet treatments into their programs as a ... see fast and effective weight loss results, it also allows ... habits to maintain their weight for the future. , Earlier ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Anti Aging ... and skin rejuvenating destination of choice, is announcing a ... October through to December. , “We’re doing this because ... possible to our top skin clinic in Toronto,” says ... do so much at Anti Aging Clinic, including laser ...
(Date:10/1/2014)... On Sept. 9, Chapín Coffee was selected ... Stewart American Made Awards (MSAMAs), an annual competition in ... the fields of crafts, design, food and style. ... in the MSAMAs, which celebrates entrepreneurs and artisans who ... communities and changing the way we shop, work and ...
(Date:10/1/2014)... 2014 Nordic Naturals is kicking ... special cause. The campaign—“Buy One Bottle. Help Two ... Veterans, a nonprofit organization that helps rebuild the ... dogs that would otherwise face euthanasia. From October ... support monthly donations of Nordic Naturals omega-3s to ...
Breaking Medicine News(10 mins):Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2
... , , , SEATTLE, July 17 ... by exacerbating conditions like hypertension, stress and fatigue, but also by causing people ... , Physicians at The Polyclinic in Seattle are offering suggestions for ... health. , , Don, t put ...
... , WASHINGTON, July 17 The Association ... Director of Policy and Public Affairs, in response to the AMA,s endorsement ... American Medical Association has sold out patients and the profession by endorsing ... "Why did the AMA do it? For a few dollars increase ...
... , , , ... (Nasdaq: NGSX ) announced today that Bruce A. Peacock has ... on his responsibilities as CEO of privately-held Alba Therapeutics. , ... no opportune time to resign, I feel confident that NeurogesX is well ...
... and avoided vitamin B deficiency , FRIDAY, July ... gastric bypass surgery helps patients lose weight faster and ... Probiotics are the "good" bacteria found in yogurt and ... University School of Medicine study included 44 patients who ...
... , CAMBRIDGE, Mass., July 17 Biopure Corporation ... The Nasdaq Stock Market, by letter dated July 17, 2009, that its ... because of concerns raised by the Company,s filing for protection under Chapter ... of business on July 28, 2009. , , ...
... , Cabinet Secretaries Kathleen Sebelius, Hilda L. ... community forum and hold m edi ... WASHINGTON , July 17 U.S. Department of ... U.S. Department of Agriculture Secretary Tom Vilsack and U.S. Department of Veterans Affairs Secretary Eric ...
Cached Medicine News:Health News:How to Afford Health Care in Hard Times 2Health News:Doctors: AMA Has Sold Out Patients & the Profession For A Few Dollars 2Health News:NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors 2Health News:NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors 3Health News:NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors 4Health News:Top Obama administration officials to hold rural health community forum 2
(Date:9/30/2014)... 2014 This study provides an analysis ... solutions including nuclear imaging informatics, PET imaging informatics, ... assesses the size of the market based on ... projects future growth based on the current drivers ... place in the broader markets for imaging equipment, ...
(Date:9/30/2014)... -- Decision Resources Group finds that the Asia Pacific ... China , India , Japan ... 2023. Dental implant procedure volumes will grow as physicians are increasingly ... Other key findings from Decision Resources Group,s coverage of the ... , Dental implant penetration: Penetration of dental implants among the ...
(Date:9/30/2014)... , Sept. 30, 2014 A study ... (OCT), offered a new look at the composition of ... how physicians understand and treat the disease, a leading ... at Baptist Health Lexington between September 2010 and May ... the Journal of the American College of Cardiology ...
Breaking Medicine Technology:Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
... Puma Biotechnology, Inc., a development stage biopharmaceutical ... license the worldwide commercial rights to neratinib, a ... transduction through the epidermal growth factor receptors, ErbB1 ... is being studied in the neoadjuvant, adjuvant and ...
... Corp. (OTCQB: CYCA), leading the way to cost effective ... Erik Stephansen to President of its eHealth division.  Mr. ... part of the company,s recent launch of their CyttaConnect™ ... network and its partners, FDA approved Bluetooth medical devices. ...
Cached Medicine Technology:Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 2Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 3Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 4Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 5New Leader for CyttaConnect™ Medical Monitoring eHealth Division 2New Leader for CyttaConnect™ Medical Monitoring eHealth Division 3